Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Rang in aandelen #2524
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aandeelprijs
$100.24
Marktkapitalisatie
$7.51B
Verandering (1 dag)
-1.84%
Verandering (1 jaar)
48.99%
Land
CH
Handel Bachem Holding AG (BANB)

Categorie

Healthcare
Koersgeschiedenis voor Bachem Holding AG (BANB)
Hoogste slotkoers: $105.12 op 2026-10-01

Laagste slotkoers: $13.47 op 2001-03-01
Koersgeschiedenis van Bachem Holding AG van 2001 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 26.87%
2025 -3.05%
2024 -5.47%
2023 -16.69%
2022 -35.59%
2021 68.81%
2020 169.92%
2019 28.96%
2018 -16.46%
2017 68.14%
2016 64.94%
2015 3.94%
2014 -8.15%
2013 45.10%
2012 -0.04%
2011 -34.01%
2010 -12.09%
2009 -5.58%
2008 -20.36%
2007 13.73%
2006 32.09%
2005 1.28%
2004 12.61%
2003 11.00%
2002 -19.59%
2001 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$535.37 25.54%
US
$185.00 589.01%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$885.21 8.73%
NL